New Ethereum Money Market Means You Can Earn Interest on Crypto
*By Tanaya Macheel and Jacqueline Corba*
Crypto start-up Compound launched money markets for Ethereum assets on Thursday.
"This allows pretty much anybody, anywhere in the world at anytime to earn interest on their Ethereum assets with a secure protocol," Compound co-Founder and CEO Robert Leshner told Cheddar's Crypto Craze.
"So if you hold Ether, if you hold a series of tokens that we're supporting, there's incremental returns."
Leshner said this open source protocol is built on Ethereum, and everything is managed directly through a smart contract.
Compound's product initially supports Ether, 0x Protocol, Basic Attention Token, and Augur. And the company's ultimate goal is to create an easy-to-use money market for investors looking to tap into this emerging market.
Crypto giant Coinbase participated in Compound's $8.2 million seed funding round back in May.
"I believe they invested, because Compound fits in with their vision of opening up access to finance to pretty much everybody around the world," Leshner said.
Other investors in the company include Andreessen Horowitz, Polychain Capital, and Bain Capital Ventures.
For full interview [click here](https://cheddar.com/videos/compound-launches-money-markets-for-ethereum-assets).
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
